Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Growth Disorders

eicosapentaenoic acid ethyl ester has been researched along with Growth Disorders in 1 studies

Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argaw, A1
Wondafrash, M1
Bouckaert, KP1
Kolsteren, P1
Lachat, C1
Belachew, T1
De Meulenaer, B1
Huybregts, L1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
ω3 Long-chain Polyunsaturated Fatty Acids for Healthy Growth and Development of Infants and Young Children in the Gilgel Gibe Hydroelectric Dam Area, Ethiopia.[NCT01817634]720 participants (Actual)Interventional2013-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for eicosapentaenoic acid ethyl ester and Growth Disorders

ArticleYear
Effects of n-3 long-chain PUFA supplementation to lactating mothers and their breastfed children on child growth and morbidity: a 2 × 2 factorial randomized controlled trial in rural Ethiopia.
    The American journal of clinical nutrition, 2018, 03-01, Volume: 107, Issue:3

    Topics: Adult; Breast Feeding; C-Reactive Protein; Child Development; Child, Preschool; Diet; Dietary Supple

2018